Ｐａｇｅ 117689 ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 通常モードに戻る ┃ ＩＮＤＥＸ ┃ ≪前へ │ 次へ≫ ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ ▼Protein Examined in ReoraWenPor 09/12/26(土) 3:11 ─────────────────────────────────────── ■題名 ： Protein Examined in ■名前 ： ReoraWenPor <amitonoloazuuz.u@gmail.com> ■日付 ： 09/12/26(土) 3:11 ■Ｗｅｂ ： http://connections.blackboard.com/people/2f62a68c8c/profile -------------------------------------------------------------------------
| A protein switch called TAK1 helps Pharmacy Nexium prevent liver damage, including inflammation, fibrosis and cancer, according to a team of scientists from the Nexium Lawsuit States and Japan. Learning more about how TAK1 works could improve understanding about the development of liver disease and cancer, and lead to new therapies, the researchers noted in their report, released online the week of Dec. 14 in advance of publication in an upcoming print issue of the Proceedings of the National Academy of Sciences. "TAK1 appears to be a master nexium tab 20mg regulator of liver function," study co-leader Dr. David A. Brenner, a professor of medicine and dean at the University of California San Diego School of Medicine, said in a university Nexium And Dry Mouth release. It was already known that nexium coupon TAK1 activates two proteins that play a role in immunity, inflammation, programmed cell death and cancer. But it wasn't clear whether TAK1 promotes or prevents liver cancer. To investigate this question, Brenner and Prescription Drug Nexium created mice with liver cells that lacked TAK1 and found that the mice had a high rate of liver cell death. To compensate, the rodents' livers produced too many Testimonials Nexium, resulting in liver damage that led to liver cancer, the researchers found. |